Get the Stockscreener App
70.37
0.92%
0.64
After Hours:
69.74
-0.63
-0.90%
Hologic Inc stock is traded at $70.37, with a volume of 2.43M.
It is up +0.92% in the last 24 hours and down -1.79% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$69.73
Open:
$69.98
24h Volume:
2.43M
Relative Volume:
1.20
Market Cap:
$15.97B
Revenue:
$4.03B
Net Income/Loss:
$789.50M
P/E Ratio:
21.13
EPS:
3.33
Net Cash Flow:
$1.15B
1W Performance:
+0.24%
1M Performance:
-1.79%
6M Performance:
-9.91%
1Y Performance:
-4.28%
1-Day Range:
$69.97
$70.97
1-Week Range:
$68.61
$70.97
52-Week Range:
$68.61
$84.67
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
70.37 | 15.97B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
604.12 | 215.18B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
240.37 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
88.54 | 43.79B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
247.79 | 36.40B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
344.69 | 25.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide - ANTARA English
Global Women's Health Crisis: Cancer Testing Plummets to 10% as Food Insecurity Surges, Hologic Reports - StockTitan
John Chevedden Submits a Shareholder Proposal to Hologic -January 16, 2025 at 04:16 pm EST - Marketscreener.com
Hologic, Inc. (NASDAQ:HOLX) Short Interest Update - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by LaFleur & Godfrey LLC - MarketBeat
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
Avanza Fonder AB Makes New $1.86 Million Investment in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
The 'coolest thing made in Delaware' may save more than 20,000 lives a year - MSN
Boston Common Asset Management LLC Has $16.41 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
FDA warns Hologic to do more to prevent harm from component in recalled implant markers - Plastics News
Hologic: Reasonably, But Not Compellingly Valued (NASDAQ:HOLX) - Seeking Alpha
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? - MSN
Earnings Preview: What To Expect From Hologic's Report - MSN
Hologic Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BioZorb Lawsuit - Lawsuit Information Center Blog
Breast Cancer Patient Advances Hologic Suit Over BioZorb Device - Bloomberg Law
Hologic receives FDA warning letter over Biozorb implantable markers - MedTech Dive
Biopsy Devices Market Global Report and Company Analysis - GlobeNewswire
Biopsy Devices Market Global Report and Company Analysis 2025-2033 Featuring Cardinal Health, Hologic, Danaher, Becton, Dickinson and Co, Boston Scientific, Medtronic, Olympus, and CONMED - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Receives $88.92 Consensus Target Price from Analysts - MarketBeat
FDA threatens Hologic with punishment for reported errors in making troubled breast device - Radiology Business
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Marlborough device maker receives FDA warning regarding implantable devices - The Business Journals
Hologic Hits New 52-Week Low: How to Play the Stock Now? - MSN
Hologic says Q1 EPS expected to be near high end of guidance ranges - MSN
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Hologic (FRA:HO1) Total Inventories : €613 Mil (As of Sep. 2024) - GuruFocus.com
Benson Investment Management Company Inc. Makes New Investment in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic's (HOLX) "Outperform" Rating Reiterated at William Blair - MarketBeat
Hologic stock hits 52-week low at $70.36 amid market shifts - Investing.com Nigeria
Clean Yield Group Grows Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic (NASDAQ:HOLX) Sets New 1-Year LowWhat's Next? - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic stock hits 52-week low at $70.36 amid market shifts By Investing.com - Investing.com South Africa
Hologic, Inc. (HOLX) Announces Board Changes Ahead of 2025 Annua - GuruFocus.com
Hologic's (HOLX) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Digital Breast Tomosynthesis Market reached US$ 3.5 billion - openPR
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
Hologic revenue increases 0.9% to USD 1,021.8M in Q1 2025 - Medical Buyer
Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return - Simply Wall St
Infectious Disease Diagnostics Market Is Booming Worldwide - openPR
Here's Why You Should Retain HOLX Stock in Your Portfolio Now - MSN
Hologic Q1 Revenue Hits $1.02B as Diagnostics Division Leads Growth with 9% Organic Surge - StockTitan
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 - The Bakersfield Californian
Diversified Trust Co Buys Shares of 7,016 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc announces board changes ahead of annual meeting By Investing.com - Investing.com Canada
Hologic Inc announces board changes ahead of annual meeting - Investing.com India
Hologic, Inc. Announces Director Retirement - Marketscreener.com
BioZorb Lawuit LawyerBreast Biopsy Marker RecallJanuary 2025 Update - Levin Papantonio
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):